|
1
|
Lai NS, Wu DG, Fang XG, Lin YC, Chen SS,
Li ZB and Xu SS: Serum microRNA-210 as a potential noninvasive
biomarker for the diagnosis and prognosis of glioma. Br J Cancer.
112:1241–1246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davies E, Clarke C and Hopkins A:
Malignant cerebral glioma-i: Survival, disability, and morbidity
after radiotherapy. BMJ. 313:1507–1512. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sathornsumetee S, Reardon DA, Desjardins
A, Quinn JA, Vredenburgh JJ and Rich JN: Molecularly targeted
therapy for malignant glioma. Cancer. 110:13–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li C, Jing H, Ma G and Liang P: Allicin
induces apoptosis through activation of both intrinsic and
extrinsic pathways in glioma cells. Mol Med Rep. 17:5976–5981.
2018.PubMed/NCBI
|
|
6
|
Chen CC, Taniguchi T and D'Andrea A: The
Fanconi anemia (FA) pathway confers glioma resistance to DNA
alkylating agents. J Mol Med (Berl). 85:497–509. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tamura R, Tanaka T, Miyake K, Yoshida K
and Sasaki H: Bevacizumab for malignant gliomas: Current
indications, mechanisms of action and resistance, and markers of
response. Brain Tumor Pathol. 34:62–77. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li C, Zheng H, Hou W, Bao H, Xiong J, Che
W, Gu Y, Sun H and Liang P: Long non-coding RNA linc00645 promotes
TGF-β-induced epithelial-mesenchymal transition by regulating
miR-205-3p-ZEB1 axis in glioma. Cell Death Dis. 10:7172019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Q, Sun S, Yu W, Jiang J, Zhou F, Qiu
G, Xu S and Jiang X: Altered expression of long non-coding RNAs
during genotoxic stress-induced cell death in human glioma cells. J
Neurooncol. 112:283–292. 2015. View Article : Google Scholar
|
|
12
|
Vital AL, Tabernero MD, Castrillo A,
Rebelo O, Tão H, Gomes F, Nieto AB, Resende Oliveira C, Lopes MC
and Orfao A: Gene expression profiles of human glioblastomas are
associated with both tumor cytogenetics and histopathology. Neuro
Oncol. 12:991–1003. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kong L, Li X, Wang H, He G and Tang A:
Calycosin inhibits nasopharyngeal carcinoma cells by influencing
EWSAT1 expression to regulate the TRAF6-related pathways. Biomed
Pharmacother. 106:342–348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song P and Yin SC: Long non-coding RNA
EWSAT1 promotes human nasopharyngeal carcinoma cell growth in vitro
by targeting miR-326/-330-5p. Aging (Albany NY). 8:2948–2960. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang GY, Zhang JF, Hu XM, Luo ZP and Ma
YZ: Clinical significance of long non-coding RNA EWSAT1 as a novel
prognostic biomarker in osteosarcoma. Eur Rev Med Pharmacol Sci.
21:5337–5341. 2017.PubMed/NCBI
|
|
16
|
Zhang R, Li JB, Yan XF, Jin K, Li WY, Xu
J, Zhao J, Bai JH and Chen YZ: Increased EWSAT1 expression promotes
cell proliferation, invasion and epithelial-mesenchymal transition
in colorectal cancer. Eur Rev Med Pharmacol Sci. 22:6801–6808.
2018.PubMed/NCBI
|
|
17
|
Fu X, Zhang L, Dan L, Wang K and Xu Y:
LncRNA EWSAT1 promotes ovarian cancer progression through targeting
miR-330-5p expression. Am J Transl Res. 9:4094–4103.
2017.PubMed/NCBI
|
|
18
|
Marques Howarth M, Simpson D, Ngok SP,
Nieves B, Chen R, Siprashvili Z, Vaka D, Breese MR, Crompton BD,
Alexe G, et al: Long noncoding RNA EWSAT1-mediated gene repression
facilitates Ewing sarcoma oncogenesis. J Clin Invest.
124:5275–5290. 2014. View
Article : Google Scholar
|
|
19
|
Sempere LF, Freemantle S, Pitha-Rowe I,
Moss E, Dmitrovsky E and Ambros V: Expression profiling of
mammalian microRNAs uncovers a subset of brain-expressed microRNAs
with possible roles in murine and human neuronal differentiation.
Genome Biol. 5:R132004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain Pathol.
20:539–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun J, Tian X, Zhang J, Huang Y, Lin X,
Chen L and Zhang S: Regulation of human glioma cell apoptosis and
invasion by miR-152-3p through targeting DNMT1 and regulating NF2:
MiR-152-3p regulate glioma cell apoptosis and invasion. J Exp Clin
Cancer Res. 36:1002017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ge S, Wang D, Kong Q, Gao W and Sun J:
Function of miR-152 as a tumor suppressor in human breast cancer by
targeting PIK3CA. Oncol Res. 25:1363–1371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Li J, Qin F and Dai S: MiR-152 as a
tumor suppressor microRNA: Target recognition and regulation in
cancer. Oncol Lett. 11:3911–3916. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
General Assembly of the World Medical
Association, . World Medical Association Declaration of Helsinki:
Ethical principles for medical research involving human subjects. J
Am Coll Dent. 81:14–18. 2014.PubMed/NCBI
|
|
25
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:(Database Issue).
D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong B, Yang T, Chen L, Kuang YQ, Gu JW,
Xia X, Cheng L and Zhang JH: Protein-protein interaction network
analysis and gene set enrichment analysis in epilepsy patients with
brain cancer. J Clin Neurosci. 21:316–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc B. 57:289–300. 1995.
|
|
29
|
Xu T, Lin CM, Cheng SQ, Min J, Li L, Meng
XM, Huang C, Zhang L, Deng ZY and Li J: Pathological bases and
clinical impact of long noncoding RNAs in prostate cancer: A new
budding star. Mol Cancer. 17:1032018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lalevee S and Feil R: Long noncoding RNAs
in human disease: Emerging mechanisms and therapeutic strategies.
Epigenomics. 7:877–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bhan A and Mandal SS: Long noncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu Y, Deng C, Zhang H, Zhang J, Peng B and
Hu C: Long non-coding RNA XIST promotes cell growth and metastasis
through regulating miR-139-5p mediated Wnt/β-catenin signaling
pathway in bladder cancer. Oncotarget. 8:94554–94568. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z and Zhang HT: Long non-coding RNA
XIST promotes TGF-β-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zong Z, Song Y, Xue Y, Ruan X, Liu X, Yang
C, Zheng J, Cao S, Li Z and Liu Y: Knockdown of LncRNA SCAMP1
suppressed malignant biological behaviours of glioma cells via
modulating miR-499a-5p/LMX1A/NLRC5 pathway. J Cell Mol Med.
23:5048–5062. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY,
Xue WQ, Chen YB, Zhang Y and Jia WH: HOTAIR, a prognostic factor in
esophageal squamous cell carcinoma, inhibits WIF-1 expression and
activates Wnt pathway. Cancer Sci. 104:1675–1682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang K, Zhao Z, Yu J, Chen W, Xu Q and
Chen L: LncRNA FLVCR1-AS1 acts as miR-513c sponge to modulate
cancer cell proliferation, migration, and invasion in
hepatocellular carcinoma. J Cell Biochem. 119:6045–6056. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Feng F, Liu H, Chen A, Xia Q, Zhao Y, Jin
X and Huang J: miR-148-3p and miR-152-3p synergistically regulate
prostate cancer progression via repressing KLF4. J Cell Biochem.
120:17228–17239. 2019. View Article : Google Scholar : PubMed/NCBI
|
